Login / Signup

Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis.

E Ann YehDennis BourdetteHeinz Wiendl
Published in: Neurology (2021)
Keyphrases
  • cell therapy
  • multiple sclerosis
  • stem cells
  • mesenchymal stem cells
  • preterm infants
  • white matter
  • gestational age